EDAP TMS receives FDA Breakthrough Device designation for Focal One in deep infiltrating endometriosis treatment.
In: M2 EquityBites (EQB), 2024-03-04
Zeitungsartikel
Zugriff:
Titel: |
EDAP TMS receives FDA Breakthrough Device designation for Focal One in deep infiltrating endometriosis treatment.
|
---|---|
Zeitschrift: | M2 EquityBites (EQB), 2024-03-04 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|